Pfizer: One of the world's premier biopharmaceutical companies
Starting with Charles Pfizer inventing an almond-flavored antiparasite medicine in 1849, our people have always been innovators and trailblazers, committed to finding the next cure. Learn More About Us Details
About - Pfizer
We’re in relentless pursuit of breakthroughs that change patients’ lives. We innovate every day to make the world a healthier place. It was Charles Pfizer’s vision at the beginning and it holds true today.
Careers | Pfizer
We’ve transformed growth and development at Pfizer to ensure that everyone can follow a path to their dream career, whether that’s climbing a traditional ladder or “zig-zagging” their way to a new role.
Pfizer-BioNTech COVID-19 Vaccine, Bivalent, and also includes information about the U.S. Food and Drug Administration (FDA)-licensed vaccine, COMIRNATY (COVID-19 Vaccine, mRNA) for use in individuals 12 years of age
New Drug Development Pipeline: Pfizer's Medicine, Vaccine …
This section defines all the terms you’ll see throughout the Pfizer Product Pipeline. You can tap the (i) wherever you see it in the experience to be brought to this glossary.
Pfizer Inc. - Investor Relations
Feb 29, 2024 · We're elevating our breakthroughs in a bold new way on Pfizer.com. Check out our new visualized product pipeline, where you'll be able to take a deep dive into our working innovations and see where each product is in development!
Our Products: Holding the Promise of a Breakthrough - Pfizer
In this section find an overview of our Pfizer Products and search for information on our most popular Pfizer products. Our products are the results of 1500 scientists overseeing more than 500,000 lab tests and over 36 clinical trials before the first prescription.
U.S. FDA Approves Pfizer’s BRAFTOVI® Combination Regimen as …
Dec 20, 2024 · BRAFTOVI in combination with cetuximab and mFOLFOX6 is the first and only combination regimen with targeted therapy approved for use as early as first-line for patients with metastatic colorectal cancer with a BRAF V600E mutation Accelerated approval is based on 61% overall response rate compared to 40% in control arm in the Phase 3 BREAKWATER ...
Pfizer and BioNTech Provide Update on mRNA-based …
Aug 16, 2024 · NEW YORK & MAINZ, Germany--(BUSINESS WIRE)-- Pfizer Inc. (NYSE: PFE, “Pfizer”) and BioNTech SE (Nasdaq: BNTX, “BioNTech”) today announced top-line results from their Phase 3 clinical trial to evaluate the companies’ combined mRNA vaccine candidate against influenza and COVID-19 in healthy individuals 18-64 years of age. The ...
Celebrating 175 Years of Changing Lives at Pfizer
Jun 24, 2024 · Pfizer was founded with the dream to deliver medicines and vaccines that would have positive impacts on global health. Nearly two centuries later, Pfizer has been at the forefront of medical and pharmaceutical breakthroughs that have not only helped to change patient lives, but shaped history.